EVPLL
Envoplakin-like protein
Also known as: EVPLL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A8MZ36
- Gene
- EVPLL
- Ensembl
- ENSG00000214860
- Chromosome
- 17
- Canonical length
- 301 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
Predicted to be involved in intermediate filament cytoskeleton organization. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
301 residues, UniProt reviewed canonical sequence.
>A8MZ36|EVPLL
1 MQASADQVER DILETQKRLQ QDRLNSEQSQ ALQHQQETGS SLKEAEVLLK DLFLDVDKAR
61 RLKHPQAEET EKDIEQLHER VTQECAEYCA LYEKMVLPPR RGIQGRLGTR AGAETEAGLR
121 RPVWAGHGGA GGTDRGAQHR AEGDQRPRRA AAEPGGAGCR HHPEPIPRPT EGGVVARAEP
181 GQPVHALQGC TWQLSALAEQ QRRILQQDWS DLMADPAGVR REYEHFKQHE LLSQEQSVNQ
241 LEEDGKRMVE LRHPAVGPIQ AHQEALKMEW QNFLNLCICQ ETQLQHVEDY SRILCPSSSP
301 HLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EVPLL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 17 nTPM
- vagina: 8.6 nTPM
- cervix: 7.3 nTPM
- skin: 6 nTPM
- liver: 2.6 nTPM
- urinary bladder: 2.6 nTPM
Single-cell type
- papillary tip epithelial cells: 11 nCPM
- renal collecting duct principal cells: 6.7 nCPM
- renal connecting tubule cells: 2.9 nCPM
- proximal tubule cells: 1.8 nCPM
- loop of henle epithelial cells: 1.7 nCPM
- renal collecting duct intercalated cells: 1.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EVPLL as an antibody target. Whether an autoantibody or antibody against EVPLL could matter depends on whether native EVPLL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EVPLL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EVPLL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...